Robbins Farley’s Thermo Fisher Scientific TMO Stock Holding History

Robbins Farley’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17	Closed	-$8K	–	205
2020 Q4	$8K	Buy	+17	New	+$7.97K	0.01%	82

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Robbins Farley's TMO Position: Q1 2021 in Review

Robbins Farley sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 17 shares — an estimated $8K sold.

Robbins Farley first reported a position in TMO in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

Robbins Farley reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
Robbins Farley sold 17 Thermo Fisher Scientific shares in Q1 2021, an estimated $8K.
Robbins Farley first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 1 quarter.
Robbins Farley's Thermo Fisher Scientific position peaked at $8K in Q4 2020.
2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Robbins Farley's 13F filing for Q1 2021, filed 13 May 2021.